Royce & Associates’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.53M | Sell |
87,029
-119,612
| -58% | -$6.22M | 0.05% | 480 |
|
|
2025
Q1 | $13.2M | Buy |
206,641
+9,642
| +5% | +$615K | 0.14% | 215 |
|
|
2024
Q4 | $9.42M | Buy |
196,999
+72,988
| +59% | +$3.49M | 0.09% | 337 |
|
|
2024
Q3 | $7.1M | Sell |
124,011
-52,716
| -30% | -$3.02M | 0.06% | 406 |
|
|
2024
Q2 | $9.25M | Sell |
176,727
-14,828
| -8% | -$776K | 0.09% | 330 |
|
|
2024
Q1 | $7.79M | Buy |
191,555
+52,245
| +38% | +$2.13M | 0.07% | 396 |
|
|
2023
Q4 | $5.15M | Buy |
+139,310
| New | +$5.15M | 0.05% | 490 |
|
|
2023
Q2 | – | Sell |
-45,000
| Closed | -$1.72M | – | 931 |
|
|
2023
Q1 | $1.72M | Sell |
45,000
-51,000
| -53% | -$1.95M | 0.02% | 686 |
|
|
2022
Q4 | $5.46M | Hold |
96,000
| – | – | 0.06% | 443 |
|
|
2022
Q3 | $3.8M | Hold |
96,000
| – | – | 0.04% | 506 |
|
|
2022
Q2 | $4.22M | Buy |
96,000
+64,000
| +200% | +$2.82M | 0.04% | 526 |
|
|
2022
Q1 | $1.28M | Buy |
+32,000
| New | +$1.28M | 0.01% | 780 |
|
|
2014
Q3 | – | Sell |
-1,200
| Closed | -$12K | – | 1415 |
|
|
2014
Q2 | $12K | Sell |
1,200
-64,875
| -98% | -$649K | ﹤0.01% | 1417 |
|
|
2014
Q1 | $839K | Sell |
66,075
-46,622
| -41% | -$592K | ﹤0.01% | 1170 |
|
|
2013
Q4 | $1.69M | Sell |
112,697
-35,000
| -24% | -$525K | ﹤0.01% | 1097 |
|
|
2013
Q3 | $1.63M | Buy |
147,697
+64,075
| +77% | +$708K | ﹤0.01% | 1106 |
|
|
2013
Q2 | $664K | Buy |
+83,622
| New | +$664K | ﹤0.01% | 1203 |
|